Platelets in Inflammatory Bowel Disease
Part of Digestive system clinical trials.
This study looks at certain blood cell markers (platelets) in people with inflammatory bowel disease (ulcerative colitis or Crohn's) to see if these markers relate to disease activity. It may help doctors better understand and monitor your condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- You must have a confirmed diagnosis of either ulcerative colitis or Crohn's disease.
- You cannot have any blood cancer or blood disorder.
- You cannot be pregnant.
- You cannot be taking blood-thinning medication (antiplatelets or anticoagulants).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether certain blood markers can help measure disease activity in people with Crohn's disease or ulcerative colitis. It involves reviewing medical records and may include a colonoscopy if you have one done as part of your routine care.
This study looks at whether people with inflammatory bowel disease (IBD) have a higher risk of blood clots when the disease is active versus in remission. It may help understand how to better prevent clotting problems.
This study looks for “biomarkers” (lab markers, like substances in blood or tissue) that may predict how Crohn’s disease or ulcerative colitis will go and how patients may respond. It may help doctors choose better monitoring or treatments in the future.
This study looks for specific body signals (called mitochondrial “DAMPs”) that may reflect active inflammation in Crohn’s disease and ulcerative colitis. It also checks how these markers relate to what doctors see during colonoscopy or flexible scope exams, to help understand inflammation and potentially guide future care.
This study looks at tissue samples from people with suspected Crohn's disease, ulcerative colitis, or indeterminate colitis. The goal is to understand these conditions better and may lead to improved treatments.
This study looks at what factors help predict how inflammatory bowel disease (IBD) may progress over time. You may be able to join if you are an adult with IBD and fit one of the study groups based on whether you have used TNF-blocking medicines before.
Hear when a new Inflammatory Bowel Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.